Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - SpyGlass Pharma Stock Jumps in First Day of Trading
SpyGlass Pharma Stock Jumps in First Day of Trading
MarketWatch

The biopharmaceutical company priced the offering at $16 a share. The stock debuted at $24, and was recently up 57%, to $25.05. SpyGlass's shares are trading on the Nasdaq Global Select Market under the symbol SGP. The company said it expects to…

time.com - Billy Perrigo - AI Could Reshape Clinical Trials-and the Business of Pharma
AI Could Reshape Clinical Trials-and the Business of Pharma
Time

Welcome back to In the Loop, TIME's new twice-weekly newsletter about AI. If you're reading this in your browser, why not subscribe to have the next one delivered straight to your inbox? We hear a lot about how AI is accelerating drug discovery.

bloomberg.com - Madison Muller - FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals
FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals
Bloomberg

The US Food and Drug Administration said it would crack down on copycat weight loss drugs like those marketed by Hims & Hers Health Inc. The telehealth company said Thursday it's selling a deeply discounted version of Novo Nordisk A/S 's new weight…

scmp.com - Julie Zhang - Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal
Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal
South China Morning Post

A unit of Fosun Pharma has struck a US$1.55 billion deal to license its home-grown cancer drug to Japan's Eisai, adding to a wave of out-licensing agreements that are channelling billions of dollars into Chinese novel drug development. The deal…

bloomberg.com - Avalon Pernell - Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
Bloomberg

SpyGlass Pharma Inc. shares jumped 50% in the biopharmaceutical firm's trading debut after it raised $150 million in an initial public offering. The company's shares traded at $24 each as of 12:12 p.m. in New York, above its IPO price of $16…

indianexpress.com - Ravi Dutta Mishra - India gains concession from US 'national-security' tariffs on metals, autos, pharma; agrees to buy soybean oil, industrial and agri goods
India gains concession from US 'national-security' tariffs on metals, autos, pharma; agrees to buy soybean oil, industrial and agri goods
The Indian Express

India has secured concessions on steel, aluminium, copper, pharma, cars and car parts that fall under Section 232 ‘national security' related tariffs, which only a few countries, such as the UK, Japan and South Korea, have received under the…

seekingalpha.com - SA Transcript Insights Editor - AptarGroup outlines 2026 margin improvement and targets 7%-11% long-term pharma core sales growth amid emergency medicine headwinds (NYSE:ATR)
AptarGroup outlines 2026 margin improvement and targets 7%-11% long-term pharma core sales growth amid emergency medicine headwinds (NYSE:ATR)
Seeking Alpha

Earnings Call Insights: AptarGroup (ATR) Q4 2025 CEO Stephan Tanda emphasized 'very strong top line performance' for Q4, with reported sales growing 14% to $963 million and core sales up 5%. Tanda noted, 'Adjusted EBITDA margin was approximately…

thehindubusinessline.com - FTA to boost Indian textiles, pharma, chemicals, agri exports as EU remains key trade partner: ICRA
FTA to boost Indian textiles, pharma, chemicals, agri exports as EU remains key trade partner: ICRA
BusinessLine

India 's recently concluded Free Trade Agreement (FTA) with the European Union is expected to deliver significant gains for several Indian sectors, including textiles, pharmaceuticals, chemicals, agriculture, leather, and marine products, as the EU…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Here's Why
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Here's Why
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $68.6950, but opened at $64.0750. Zealand Pharma A/S shares last traded at $64.0750, with a volume of 153…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - Here's What Happened
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - Here's What Happened
MarketBeat

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $63.73, but opened at $70.07. BridgeBio Pharma shares last traded at $68.4410, with a volume of 782,051 shares…

marketbeat.com - Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX
Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX
MarketBeat

Thrivent Financial for Lutherans lowered its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 211,305 shares of the…

prweb.com - www.pda.org - PDA Introduces the 2026 Board of Directors and Officers
PDA Introduces the 2026 Board of Directors and Officers
PRWeb

'I congratulate Melissa Seymour for assuming the position of PDA Chair and thank Anil Sawant for his leadership in that position over the last two years,' said Glenn Wright, PDA President and CEO. 'I also want to welcome Ken Paddock and Jackie…

thehindu.com - The Hindu Bureau - CII meet stresses safety culture in high-risk industries
CII meet stresses safety culture in high-risk industries
The Hindu

The CII Andhra Pradesh Conference on Industrial Safety and Environmental Protection in High-Risk Factories held on Friday here aimed to strengthen safety and sustainability across chemical, pharmaceutical and other high-risk industries. The…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer released data for its asundexian drug candidate for stroke prevention that seem better…

wsj.com - Brian Gormley - Slate of Biotechs Heads to the Public Markets, Spurring Optimism
Slate of Biotechs Heads to the Public Markets, Spurring Optimism
Wall Street Journal

Biotechnology companies going public this week are signaling a resurgence for initial public offerings and venture-capital investment in the sector this year. Biotechs Eikon Therapeutics and Veradermics staged initial public offerings this week…

Receive a Daily briefing on Pharma Industry News

Get Started